Physician profile
Mary E Cyr
NPI 1447382601
$2,011.16
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,821 · 2020: $133 · 2021: $14.84 · 2023: $19.88 · 2024: $22.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $376.10 | 2019-2020 | |
| Novo Nordisk INC | $183.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.97 | 2019-2020 | |
| Glaxosmithkline, LLC. | $141.54 | 2019-2024 | Shingrix, Arexvy |
| Abbvie INC. | $141.46 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $138.31 | 2019 | |
| Pfizer INC. | $120.15 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $120.13 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $118.50 | 2019 | |
| Lilly USA, LLC | $79.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $78.33 | 2019 | |
| Avanir Pharmaceuticals, INC. | $49.35 | 2019 | |
| Daiichi Sankyo INC. | $48.49 | 2019-2020 | |
| Celgene Corporation | $45.52 | 2019 | |
| Mylan Specialty L.P. | $35.52 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $33.89 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $20.37 | 2019 | |
| Amarin Pharma, INC. | $18.19 | 2019 | |
| Merck Sharp & Dohme LLC | $17.17 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.39 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.31 | 2019 | |
| Phadia US INC. | $16.06 | 2019 | |
| Allergan, INC. | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Cyr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.